₹29.84
▲ +0.1 +0.34%
As of 11 Sept 2026 · delayed
BSE Listed
Prism Medico & Pharmacy Ltd. (512217)
Volume: 2,535Avg Vol 1W: 5,194Avg Vol 1M: 6,04852W Range:₹15.51₹34.49
Key Ratios
Checked 6h agoMarket Cap₹40 Cr
Current Price₹29.84
Previous Close₹29.74
High / Low (52w)₹34.49 / ₹15.51
Volume2,535
Avg Vol (1W)5,194
Avg Vol (1M)6,048
Stock P/E118.7
Book Value₹16.89
Dividend Yield0%
ROE206.6%
ROA-249.84%
Revenue (TTM)—
Revenue Growth—
Profit Margin-45.88%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B1.77
Debt / Equity0.17
50 DMA₹28.71
200 DMA₹25.23
Day change+0.34%
Price Chart
₹29.84▲ 80.96% · 1Y
2025-09-112026-09-11
20-day avg volume: 6K shares
Pros
- Healthy return on equity of 206.6%.
- Company is almost debt-free.
Cons
- Revenue fell 100% YoY.
- Company is loss-making at the latest annual result.
- Stock trades at a high P/E of 119.
Quarterly Results
| Metric | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹6 Cr | ₹15 Cr | ₹17 Cr | ₹17 Cr | ₹9 Cr | ₹7 Cr | ₹10 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Balance Sheet
| Metric | Mar 2017 | Mar 2018 | Mar 2019 |
|---|---|---|---|
| Total Assets | ₹17 Cr | ₹16 Cr | ₹21 Cr |
| Total Liabilities | ₹4 Cr | ₹3 Cr | ₹8 Cr |
| Equity | ₹13 Cr | ₹13 Cr | ₹13 Cr |
| Total Debt | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 |
|---|---|---|
| Operating | ₹4 Cr | ₹0 Cr |
| Investing | ₹-3 Cr | ₹0 Cr |
| Financing | ₹-2 Cr | ₹-1 Cr |
| Free Cash Flow | ₹4 Cr | ₹0 Cr |
Shareholding
Promoter 29.98% Institutions 0% Public 70.02%
Efficiency & Working Capital
ROCE2.8%
Interest Coverage2.2
Dividend Payout—
Debtor Days21 d
Inventory Days9 d
Payable Days39 d
Cash Conversion Cycle-8 d
Working Capital Days30 d
Shareholding Details
As of 2026-06-30
Promoter30%
FII0%
DII0%
Institutions0%
Public70%
Promoter Pledge0%
No. of Shareholders4,177
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | May 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25.5% | 30.2% | 30% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 74.5% | 69.8% | 70% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 3,650 | 3,792 | 3,866 | 4,107 | 4,178 | 4,302 | 4,306 | 4,315 | 4,306 | 4,295 | 4,300 | 4,177 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Dharmender Kharb | Public Shareholding | 19.4% | 26,25,000 |
| Symbiosis Pharmaceuticals Private Limited | Shareholding of Promoter and Promoter Group | 15.7% | 21,23,083 |
| Galaxy Vitacare Private Limited | Shareholding of Promoter and Promoter Group | 13.3% | 17,97,672 |
| Raju Tyagi | Public Shareholding | 9.8% | 13,25,000 |
| Sejal S Nashatar | Public Shareholding | 2.5% | 3,40,000 |
| Shilpa Harsh Rupareliya | Public Shareholding | 2.4% | 3,30,000 |
| Harsh Jentibhai Rupareliya | Public Shareholding | 2.4% | 3,30,000 |
| Anshul Jajoo | Public Shareholding | 1.4% | 1,90,150 |
| Bosco Armando Menezes | Public Shareholding | 1.1% | 1,50,000 |
| Emily Bosco Menezes | Public Shareholding | 1.1% | 1,50,000 |
| Ramit Walia | Shareholding of Promoter and Promoter Group | 1.1% | 1,45,106 |
| Reeta Devi | Public Shareholding | 1% | 1,39,669 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Sakshi Laller | Whole-time Director | 2025 |
| Davender Singh | Director | 2025 |
| DINESH KUMAR | Independent Non Exe. Director | 2025 |
| Pradeep Kumar | Independent Non Exe. Director | 2025 |
| Sameer Gupta | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 25 | 6 | 6 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-12 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 4 | 4 |
| 2026 | 0 | 0 | 0 | 0 | 1 | 1 |
| 2026 | 0 | 0 | 0 | 0 | 2 | 2 |
Substantial Acquisitions (SAST)
4 disclosure(s)
Market18/08/2021 · 22,165
Market12/08/2021 · 11,320
Market06/08/2021 · 25,000
Market26/07/2021 - 27/07/2021 · 65,000
Company Information
🌐 www.prismmedico.in ↗
📍 D-118 Industrial Area, Phase VII, Mohali, Punjab, 160055
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Capricorn Systems Global Solutions Ltd.Vama Industries Ltd.Sunteck RealtyBentley Commercial Enterprises Ltd.Silver Oak Commercial Ltd.Classic Electricals Ltd.SPV Global Trading LimitedVeritas (India) Ltd.Jaybharat Textiles & Real Estate Ltd.Jai CorpNivi Trading Ltd.Ashirwad Capital Ltd.All “51” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search